1. Adriamycin (NSC123127)-cardiomyopathy: an overview with determination of risk factors;Minow;Cancer Chemother Rep,1975
2. Liposomal protection of adriamycin-induced cardiotoxicity in mice;Rahman;Cancer Res,1980
3. use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity in mice;Forssen,1981
4. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumour activity in mice;Gabizon;Cancer Res,1982
5. Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes;Olson;Eur J Cancer Clin Oncol,1982